Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. (CRON) generates frequent news as a cannabinoid-focused company active in medical and adult-use cannabis markets across Canada, Israel and multiple international regions. Company updates often highlight brand performance, international expansion, product launches and financial results, offering investors and industry observers insight into how Cronos executes its global cannabis strategy.
News coverage for Cronos commonly includes quarterly earnings releases, where the company reports net revenue, gross profit, adjusted EBITDA and commentary on business performance by geography and brand. These releases also describe developments such as the consolidation and expansion of cultivation operations at Cronos Growing Company Inc. (Cronos GrowCo) and the company’s cash and short-term investment position.
Another major category of Cronos news involves brand and product announcements. Recent press releases describe new SOURZ by Spinach® Fully Blasted multipack gummies, seasonal Spinach® Caramel Green Apple gummies and vapes, and Lord Jones® Live Resin Fusions™ pre-rolls in Canada. These updates show how Cronos uses its Spinach® and Lord Jones® brands to introduce new formats and flavor profiles in the Canadian adult-use market.
Cronos also issues news on its international footprint and strategic transactions. Examples include the expansion of PEACE NATURALS® medical cannabis distribution in Switzerland through a partnership with Dascoli Pharma AG, and a definitive agreement for a Cronos subsidiary to acquire CanAdelaar B.V., a licensed producer in the Netherlands’ adult-use cannabis pilot program. In addition, the company has announced a junior secured convertible loan investment in High Tide Inc., a cannabis retailer, outlining the terms of that financing.
Investors and followers of CRON can use this news feed to review earnings announcements, track new product introductions under Spinach®, PEACE NATURALS® and Lord Jones®, and monitor strategic moves such as international partnerships, acquisitions and capital investments.
Cronos Group (NASDAQ: CRON) has appointed Anna Shlimak as Chief Financial Officer, effective March 19, 2025. Shlimak, previously serving as Chief Strategy Officer, succeeds James Holm who will remain with the company through April 18, 2025 to ensure a smooth transition.
Shlimak has been a key member of Cronos' leadership team for seven years, where she has led strategic initiatives in cost optimization, revenue growth, and corporate brand building. CEO Mike Gorenstein expressed confidence in Shlimak's ability to drive financial strategy and growth, citing her deep understanding of the business and track record in driving financial performance.
James Holm, departing after two and a half years, will pursue other opportunities after contributing to improving the company's finance functions and building a robust finance team.
Cronos Group (NASDAQ: CRON) (TSX: CRON), a global cannabinoid company, has announced its participation in the upcoming 37th Annual Roth Conference. Mike Gorenstein, who serves as Chairman, President and CEO, will deliver a presentation on Monday, March 17, 2025, at 1:00 PM PT.
Investors and interested parties can access a live webcast of the presentation through the Investors section of Cronos Group's website at ir.thecronosgroup.com/events-presentations.
Cronos Group (NASDAQ: CRON) reported strong financial results for Q4 and full-year 2024, with Q4 net revenue increasing 27% year-over-year to $30.3 million and full-year revenue up 35% to $117.6 million.
Key highlights include:
- Spinach® ended 2024 as the #1 cannabis brand in Canada, with 5.7% market share in flower category
- PEACE NATURALS® achieved #1 position in Israel with 24% market share
- Company maintains strong balance sheet with $859 million in cash
- Q4 2024 gross profit increased to $10.8 million, up from $1.9 million in Q4 2023
- Adjusted EBITDA improved to $(7.2) million in Q4 2024, a $7.6 million improvement year-over-year
The company expanded operations through Cronos GrowCo investment, enhanced cultivation capabilities, and strengthened international presence in Germany and UK markets.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has announced its upcoming 2024 fourth-quarter and full-year earnings conference call, scheduled for Thursday, February 27, 2025, at 8:30 a.m. ET.
The company's senior management team will present financial results and participate in a Q&A session with the investment community.
Interested participants are encouraged to register online at the company's investor relations website and dial in fifteen minutes before the scheduled start time to avoid delays. The webcast will be archived on Cronos' website for later viewing.
Cronos Group (NASDAQ: CRON) reported strong Q3 2024 results with net revenue increasing 38% year-over-year to $34.3 million. The Spinach® brand became the #1 cannabis brand in Canada, leading in edibles with 17.2% market share. The company maintains a robust balance sheet with $862 million in cash and cash equivalents. Cronos completed its investment in Cronos GrowCo, gaining majority board control and consolidating results from July 2024. Despite a gross profit decrease of 9% to $3.6 million, Adjusted Gross Profit increased 170% to $10.7 million, and Adjusted EBITDA improved by 60% to $(6.0) million.
Cronos Group (NASDAQ: CRON) (TSX: CRON) has scheduled its 2024 third quarter earnings conference call for Tuesday, November 12, 2024, at 8:30 a.m. ET. The company's senior management will present financial results and take questions from the investment community. Participants are encouraged to register online and dial in fifteen minutes before the scheduled start time to avoid delays. A webcast replay will be available on the company's website after the call.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announces that its brand Spinach® has become the best-selling cannabis brand in Canada, according to HiFyre Retail Analytics for August 2024. Spinach ranks first in both edibles and flower categories. Launched in November 2018, Spinach has quickly gained popularity among adult consumers.
Mike Gorenstein, Chairman, President and CEO of Cronos, states that this success validates their portfolio and innovation capabilities. Jeff Jacobson, Chief Growth Officer, attributes the brand's success to its focus on enhancing the adult consumer experience. Cronos emphasizes its commitment to quality, innovation, and product development, with plans for more innovative offerings under the Spinach® brand.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is expanding its Lord Jones® brand portfolio in Canada with new cannabis product innovations. The company has introduced new cultivars for Lord Jones® Ice Water Hash Fusions Pre-Rolls and Live Resin Vapes, now available nationwide. Since its Canadian launch in November 2023, Ice Water Hash Fusions Pre-Rolls have become the best-selling hash-infused pre-rolls in the country. As of July 2024, Lord Jones® has also become the third best-selling live resin vape brand in Canada.
New offerings include Sour Blueberry and Snow Lotus x Animal Mints pre-rolls, featuring 35-41% THC content. The Live Resin Vapes, available in all-in-one devices and 510-cartridges, offer 70+% THC with the new Gorilla Z flavor. These products aim to provide premium, potent experiences for adult consumers, reinforcing Cronos' commitment to product innovation in the Canadian cannabis market.
Cronos Group (NASDAQ: CRON) reported strong Q2 2024 results, with net revenue increasing 46% year-over-year to $27.8 million. The growth was driven by a 46% increase in Canada, 27% in Israel, and new sales in Germany and the UK. The company's gross profit rose 103% to $6.3 million, while Adjusted EBITDA improved by $4.9 million to -$11.1 million. Cronos maintains a strong balance sheet with $848 million in cash and cash equivalents.
Key highlights include the expansion of Cronos GrowCo, intended to fuel global growth, and the success of brands like Spinach®, which leads in Canada's edibles and flower categories. The company reiterated its operating expense savings target of $5-$10 million for 2024 but no longer anticipates a positive net change in cash due to the $51 million investment in Cronos GrowCo.
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has announced its upcoming 2024 second quarter earnings conference call, scheduled for Thursday, August 8, 2024, at 8:30 a.m. ET. The company's senior management team will present financial results and be available for questions from the investment community. Participants are encouraged to register online at the Cronos Group website to attend the call or webcast. To ensure a smooth experience, attendees are advised to dial in fifteen minutes before the scheduled start time. For those unable to attend live, a replay of the webcast will be archived on the company's website for later viewing.